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Summary
Objective: Patients with genetic generalized epilepsy (GGE) have subtle morpho-
logic abnormalities of the brain revealed with magnetic resonance imaging (MRI),
particularly in the thalamus. However, it is unclear whether morphologic abnor-
malities of the brain in GGE are a consequence of repeated seizures over the
duration of the disease, or are a consequence of treatment with antiepileptic drugs
(AEDs), or are independent of these factors. Therefore, we measured brain mor-
phometry in a cohort of AED-naive patients with GGE at disease onset. We
hypothesize that drug-naive patients at disease onset have gray matter changes
compared to age-matched healthy controls.
Methods: We performed quantitative measures of gray matter volume in the tha-
lamus, putamen, caudate, pallidum, hippocampus, precuneus, prefrontal cortex,
precentral cortex, and cingulate in 29 AED-naive patients with new-onset GGE
and compared them to 32 age-matched healthy controls. We subsequently com-
pared the shape of any brain structures found to differ in gray matter volume
between the groups.
Results: The thalamus was the only structure to show reduced gray matter volume
in AED-naive patients with new-onset GGE compared to healthy controls. Shape
analysis revealed that the thalamus showed deflation, which was not uniformly dis-
tributed, but particularly affected a circumferential strip involving anterior, superior,
posterior, and inferior regions with sparing of medial and lateral regions.
Significance: Structural abnormalities in the thalamus are present at the initial
onset of GGE in AED-naive patients, suggesting that thalamic structural abnor-
mality is an intrinsic feature of GGE and not a consequence of AEDs or disease
duration.
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1 | INTRODUCTION
People with genetic generalized epilepsy (GGE) are expected
to have normal neuroimaging findings when studied with a
conventional clinical magnetic resonance imaging (MRI)
scan.1,2 However, subtle abnormalities of brain morphology
have frequently been reported. There are conflicting findings
regarding which brain regions are involved and whether the
abnormality consists of increased or reduced volume of
particular brain regions. Gray matter atrophy in the puta-
men,3,4 caudate,4 globus pallidus,3 and hippocampus5 has
been identified inconsistently across studies in patients with
GGE compared to healthy controls. The thalamus has shown
the most consistent differences, typically volume loss,3,4,6,7 in
patients with GGE. Morphologic abnormalities of cortex, in
particular prefrontal, precentral, and posterior cingulate, have
also been reported, although inconsistently.6,8–11
Prior studies of brain morphology in GGE have been
carried out in populations of patients with a longstanding
diagnosis and on long-term antiepileptic drug (AED) treat-
ment; both factors could affect brain morphology.12,13 This
precludes unequivocal attribution of abnormalities in brain
morphology to the underlying etiology. There is only one
previous study that reported decreased thalamic volume in
a group of drug-naive patients with GGE, in this case chil-
dren with childhood absence epilepsy (CAE), although they
were studied on average a year after the first diagnosis.14
In the work reported herein, we measured brain mor-
phology at the earliest possible time point in AED-naive
patients diagnosed with GGE. We hypothesize that AED-
naive patients at disease onset will have differences in gray
matter volume compared to age-matched healthy controls.
All subjects were recruited through rapid-access first sei-
zure clinics and scanned within a week of initial diagnosis,
before commencing AEDs.
2 | METHODS
2.1 | Subjects
We acquired data from 29 AED-naive patients with GGE
(mean age 15.07, standard deviation [SD] 7.8 years, range
5.9-37.0 years) recruited from first seizure clinics across
London. Inclusion criteria were the following: (1) diagnosis
of GGE made by an epilepsy specialist following examina-
tion and investigation; (2) normal cognitive development;
and (3) if a child, judged by their treating clinician to be
capable of undergoing an MRI scan without sedation.
Exclusion criteria were the following: (1) a history of any
neurologic condition other than epilepsy; and (2) current
use of drugs active in the brain (prescribed medications
and drug or alcohol misuse).
We studied 32 age-matched healthy controls (mean age
16.9, SD 7.3 years, range 6.6-32.0 years) to compare with the
AED-naive patients with GGE (Mann-Whitney U = 383.5,
P = .245). Inclusion criteria were if a child, judged to be cap-
able of undergoing MRI scan without sedation. Exclusion cri-
teria were the following: (1) current use of drugs active in the
brain (prescribed medications and drug or alcohol misuse); (2)
history of any neurologic or neurodevelopmental conditions;
and (3) family history of epilepsy in any first-degree relative.
The study was approved by the Riverside Research Ethics
Committee (REC approval number 12/LO/2006) and by the
London-Surrey Border Research Ethics Committee for the
acquisition of pediatric healthy controls (REC approval num-
ber 11/LO/1421). Written informed consent was obtained
from all participants. A parent or the nominated legal carer
gave informed and written consent on behalf of the participant
if younger than the age of 18.
A full list of the demographic characteristics of the
patients is shown in Table 1.
2.2 | MRI acquisition
Fourteen patients and 16 healthy controls from age 5 to
13 were studied at UCL Great Ormond Street Institute
Key Points
• Brain morphology was studied in newly diag-
nosed AED-naive patients with GGE for the first
time
• Bilateral thalamus was smaller in patients than in
healthy controls
• Thalamic volume loss in GGE is present at dis-
ease onset, independent of AEDs and repeated
seizures
• We proposed that thalamic volume loss in GGE
is a disease endophenotype
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of Child Health, London, using a three-dimensional (3D)
isotropic T1-weighted FLASH sequence in the sagittal
plane (echo time [TE] 4.94 msec, repetition time [TR]
11 msec, acquisition matrix 192 9 256 9 176, field of
view 256 mm, voxel size 1 9 1 9 1 mm) using a 1.5T
Siemens Avanto scanner. Fifteen patients and 16 healthy
controls from age 13 to 37 were studied at King’s Col-
lege London using a 3D T1-weighted IR-SPGR sequence
in the sagittal plane (TE 3.016 msec, TR 7.312 msec,
acquisition matrix 256 9 256 9 196, field of view of
270 mm, voxel size 1.05 9 1.05 9 1.2 mm) using a 3T
750 General Electric scanner.
2.3 | MRI analysis
Based on published literature in the field we hypothesized that
the effects of interest would be seen in a set of candidate brain
regions: bilateral thalamus, putamen, caudate, pallidum, hip-
pocampus, precuneus, prefrontal cortex, precentral cortex, and
cingulate. We therefore confined our analysis to these regions.
2.4 | Volumetric analysis (subcortical and
cortical)
We used FSL-integrated registration and segmentation tool-
box (FSL-FIRST) software, version 5.0 (http://fsl.fmrib.ox.ac.
uk/fsl/fslwiki/first) (Analysis Group, FMRIB, Oxford, United
KIngdom) for the automated segmentation of bilateral thala-
mus, putamen, caudate, pallidum, and hippocampus. As
described in detail elsewhere,7,15 FSL-FIRST automatically
segmented the subcortical structures from the MR images and
produced volumetric outputs. Cortical regions of interest
(ROIs) were segmented using standard “recon-all” processing
stream implemented in Freesurfer software (http://freesurfer.-
net/)16 (The General Hospital Corporation, Boston, MA,
USA) which supplies the surfaces and morphometry data for
each subject. FSLstats (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
Fslutils) (Analysis Group, FMRIB) was used to measure each
structure’s global volume (Figure 1).
Left and right gray matter volumes were extracted sepa-
rately, and the mean volume for each ROI was calculated
as the mean across hemispheres. Normalized brain volume
(NBV) was measured using SienaX17,18 and included as a
covariate in the analyses of cortical and subcortical areas to
control for its effect. This methodologic choice was sup-
ported by evidence showing that volumes of the subcortical
areas of interest are correlated positively with the cranium
size19 and that SienaX measures are an excellent surrogate
for the intracranial vault volume.20
2.5 | Shape analysis
FSL-FIRST outputs parameterized volumetric labels (meshes)
from surfaces after affine registration of raw T1-weighted
images to Montreal Neurological Institute (MNI) 152 space.
Vertex-wise shape analysis along the surface of the segmented
structures was performed via the measures of differences in
mean vertex position between AED-naive patients and healthy
controls7,15 only for those ROIs where differences had been
found in the volumetric analysis using FSL software.
2.6 | Statistical methods
Volumetric measures of cortical and subcortical areas were
included in a general linear model as the dependent variables.
For each area, a comparison was made between AED-naive
TABLE 1 Demographics and clinical details of the patients
Gender Age at scan (Y) Syndrome Seizures
M 6.0 CAE Absence
M 10.5 JAE Absence
M 6.3 CAE Absence
M 10.5 JAE Absence
F 13.6 JAE Absence
M 8.0 CAE Absence
F 7.7 CAE Absence
M 10.2 JAE Absence
F 9.7 CAE Absence
M 7.1 CAE Absence
M 9.2 CAE Absence
M 5.9 CAE Absence
M 6.8 JAE Absence, GTCS
F 13.5 JAE Absence
M 21.7 GTCSO GTCS
M 16.7 GTCSO GTCS
F 16.5 JME Myoclonus, GTCS
F 13.6 JME Myoclonus, GTCS
F 20.1 JME Myoclonus, GTCS
F 15.3 JME Myoclonus, GTCS
F 17.6 JME Myoclonus, GTCS
F 26.0 JME Myoclonus, GTCS
M 14.4 JME Myoclonus, GTCS
F 25.9 GTCSO GTCS
F 31.2 JME Myoclonus, GTCS
F 16.4 GTCSO GTCS
M 20.8 JME Myoclonus, GTCS
F 19.1 JME Myoclonus, GTCS
F 37.0 GTCSO GTCS
F, female; M, male; CAE, childhood absence epilepsy; JAE, juvenile absence
epilepsy; GTCSO, generalized tonic–clonic seizure only; JME, juvenile myo-
clonic epilepsy; GTCS, generalized tonic–clonic seizure; Y, age in years.
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patients and controls, modeling age, gender, scanner type, and
NBV as covariates. Note that because these covariates (age,
gender, scanner type, and NBV) are effects of no interest, any
correlations between them are unimportant. A Bootstrapping
procedure was used to determine statistical significance so that
parametric assumptions regarding model error were avoided.
The data were sampled with replacement 5000 times. False dis-
covery rate (FDR) was used to control for multiple compar-
isons across the 9 ROIs (q < 0.05). Results are presented with
regression coefficients (b) representing brain volume changes
and 95% confidence interval (CI). For the shape analysis, 5000
permutation testing using “randomize”21 was used to calculate
statistics from surface meshes of the segmented structures
included in the general linear model (GLM), which were
thresholded at q < 0.05 and corrected for multiple comparisons
using FDR. Age, gender, scanner type, and NBV were also
included as covariates in this model.
3 | RESULTS
Twenty-nine patients and 32 controls were included in the
analysis. The quality of subcortical and cortical segmenta-
tion was inspected visually. All patients passed a quality
check for the subcortical segmentation in which the seg-
mented areas were overlaid on each individual T1-weighted
image to verify anatomic correspondence between areas of
interest. However, 3 patients were excluded from the
cortical volumetric measures due to motion corruption that
prevented accurate cortical segmentation.
3.1 | Volumetric analysis
We found a reduction in the volume of the thalamus aver-
aged across hemispheres in newly diagnosed AED-naive
patients compared to healthy controls, corrected for multiple
comparisons using FDR (corrected q = 0.032, b = 434.322,
CI [179.162, 717.241]). Putamen (uncorrected P = .03, cor-
rected q = 0.1, b = 210.88, CI [12.687, 453.675]) and pal-
lidum (uncorrected P = .01, corrected q = 0.06, b = 74.6,
CI [20.642, 134.852]) showed a trend toward volume reduc-
tion in newly diagnosed AED-naive patients compared to
healthy controls but did not reach statistical significance after
correction for multiple comparisons.
Hippocampus, caudate, prefrontal cortex, precentral cor-
tex, precuneus, and cingulate volumes did not show any
differences between newly diagnosed AED-naive patients
compared to healthy controls (Figure 1).
FIGURE 1 Cortical and subcortical
volumetric segmentation. Gray matter
masks of the cortical and subcortical areas
selected for volumetric analysis between
patients and controls. Average volumes and
standard deviations for each area in the
healthy control and AED-naive group are
reported in mm3
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Differences found in the subcortical volumes were not
influenced by different acquisitions, as we found no statisti-
cally significant difference in the thalamic volume of the
healthy controls between scanners (F[2,29] = 0.014,
P = .880).
3.2 | Shape analysis
We explored the shape of bilateral thalami, as this was the
only ROI showing significant volumetric difference
between AED-naive patients with new-onset GGE and
healthy controls. We found that left and right thalami
showed differences in shape between the groups. There
was relative deflation affecting a circumferential strip run-
ning in an anterior-posterior orientation, incomplete inferi-
orly, with sparing of medial and lateral aspects (Figure 2).
The results of the shape analysis are displayed in Figure 3,
where they are overlaid on the Morel atlas.22
4 | DISCUSSION
For the first time, we measured brain morphology in an
AED-naive population with GGE, within a week of first
diagnosis, in which history suggested a seizure onset very
close to the time of diagnosis. Our unique sample of
patients allowed us to separate gray matter morphologic
abnormalities from the effects of AED treatment and dis-
ease duration, which have confounded results of prior stud-
ies in this field. Our AED-naive newly diagnosed patient
group showed a decrease in volume of the thalamus com-
pared to healthy controls, associated with deflation of the
FIGURE 2 AED-naive thalamic shape
change. Bilateral changes in thalamic shape
between healthy controls and AED-naive
patients are in red; the mask of thalamus is
in green
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anterior, posterior, and midline aspects and relative sparing
of medial and lateral aspects. In this study, we did not find
evidence of morphologic abnormality in putamen, caudate,
pallidum, hippocampus, precuneus, prefrontal cortex,
precentral cortex, or cingulate.
Thalamus is the brain area that has shown most con-
sistent differences between patients with established GGE
on AED treatment and healthy control subjects across
studies, typically revealing volume loss. The pattern of
thalamic volume loss that has been reported to be atypi-
cal in GGE is consistent with our results. For example,
patients with generalized tonic–clonic seizures only
(GTCSO) revealed reduced gray matter in the ventral
anterior and lateral nuclei of the thalamus compared to
healthy controls.3,23,24 In a group of patients with juve-
nile myoclonic epilepsy (JME), shape analysis showed
surface reduction in the medial and lateral nuclei of
bilateral thalami,25 and decreased gray matter volume in
the anteromedial thalamus has also been found in
patients with JME11 and in a group of mixed GGE
patients.26 Similarly, gray matter volume reduction in
bilateral thalami has been reported in patients with
CAE.9 However, inconsistent results of increased thala-
mic gray matter volume was reported in CAE27; and no
difference between GGE patients and healthy controls
has also been reported.4
Although there is more consistent evidence supporting
thalamic volume loss in GGE, additional areas of the basal
ganglia have also been found abnormal in patients with
GGE, although more inconsistently. For example, deflation
of the putamen and pallidum was reported in a group of
patients with GTCSO3; and in a further group with
GTCSO, gray matter reduction was found in the cerebel-
lum.10 In a group of patients with JME, shape analysis
showed surface reduction in bilateral hippocampi.25 In an
exploratory analysis of our data, we looked for shape dif-
ferences between our GGE patients and healthy controls in
hippocampi, putamen, and caudate; we found no significant
shape differences in any part of any of these regions.
A similar inconsistency has been found in abnormalities
of cortical areas. For example, an increase in volume has
been found in the medial frontal cortex of patients with
JME,11,28 whereas another study of JME patients found a
decrease in a similar region.8 In addition, medial frontal
gyrus was found to have decreased gray matter volume in
groups of patients with GTCSO.10,23 In our study, we did
not find any cortical areas of differences between GGE
patients and healthy control, unlike these previous reports.
FIGURE 3 Correspondence between
thalamic shape change and thalamic nuclei.
Overlay of the Morel atlas on regions
showing shape change comparing AED-
naive patients with GGE and healthy
controls. A list of thalamic nuclei is on the
right. Medial group: MV, medioventral
nucleus; CL, central lateral nucleus; CeM,
central medial nucleus; CM, centromedian
nucleus; Pf, parafascicular nucleus; sPf,
subparafascicular nucleus. Posterior group:
PuM, medial pulvinar; PuL, lateral
pulvinar; LP, lateral posterior nucleus; SG,
suprageniculate nucleus; Li, limitans
nucleus; Po, posterior nucleus. Lateral
group: VPM, ventral posterior medial
nucleus; VLa, ventral lateral anterior
nucleus; VLpd/VLpv, ventral anterior
nucleus dorsal and ventral parts; VAmc/
VApc, ventral anterior nucleus
magnocellular and parvocellular parts; VM,
ventral medial nucleus. Anterior group:
AM, anterior medial nucleus; AV, anterior
ventral nucleus; LD, lateral dorsal nucleus
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Furthermore, our results did not show abnormalities in any
subcortical areas in addition to the thalamus. However,
given that a trend in decreased gray matter volume in puta-
men and pallidum was found, and in accordance with a
previous report studying long-term GGE patients on medi-
cation,3 we can speculate that changes in these structures
may become more pronounced due to the potential effects
of disease duration and medication.29
Whether different GGE syndromes have features or
endophenotypes in common is a matter of debate; here, we
have assumed thalamic atrophy may be a shared feature
between GGE syndromes. Although it would have been of
interest to explore potential differences between syndromes,
we could not test for differences between syndromes inde-
pendent from the effect of scanner and imaging sequence,
although there is evidence showing that measurements
made on different scanners are reliable.19,30 This was due
to the practical and ethical constraints of the study, where
children were scanned on a 1.5T scanner at a pediatric
focused site and adults on a 3T scanner at a different site.
All the previously published reports are derived from
populations of patients entirely composed of, or biased
toward, (1) refractory GGE, (2) taking long-term AED
treatment, and (3) with long disease durations. These con-
founding factors may account for the contrasting results
reported between groups of patients and groups of healthy
controls across studies. For example, gray matter volume
(cortical and subcortical) has been reported to be negatively
correlated with disease duration in GGE,7,10,14,24 although
some studies did not find thalamic volume and disease
duration to be correlated,3,23 which may relate to the
patient group selected, or to other factors such as seizure
frequency or AED treatment. The effect of AED treatment
is unclear: although reports of animal studies have indi-
cated effects on brain development, there are only case
reports available in humans that confirm these
effects.13,31,32
In our study, we investigated drug-naive patients with
GGE at the immediate onset of their condition, within a
few days of first presentation to a rapid-access first seizure
clinic. Selecting only drug-naive GGE patients at the
immediate onset of their condition has allowed us to con-
trol for disease duration and medication effects. There is
only one previous study that reported decreased gray matter
volume in a group of drug-naive CAE early in their dis-
ease.14 However, these patients were studied at an average
of 1.86  0.86 years between disease onset and time of
scanning, which is potentially significant in the context of
interactions between ongoing brain growth and develop-
ment and seizures. Hence it is not clear whether the thala-
mic morphologic abnormality reported would have been
present at the onset of epilepsy. Furthermore, in a cohort of
CAE patients scanned twice (baseline within a few months
of first diagnosis and then again 2 years later) and who
were receiving AED treatment at both time points, there
was evidence of thalamic volume loss at the end of the 2-
year interval, suggesting that disease and/or treatment fac-
tors may impact thalamic volume early in the disease
course.33 It is important to note that evidence from our
study suggests that thalamic volume loss is present at epi-
lepsy onset and is therefore likely to be an underlying dis-
ease feature, not a consequence of AED treatment or
recurring seizures over a prolonged period.
The involvement of the thalamus in the pathogenesis of
generalized spike-wave discharges (GSWs), the electroen-
cephalography (EEG) hallmark of GGE, has been well
established. Thalamocortical circuits are believed to play an
important role in the pathogenesis of GGE in experimental
animal models.34 In humans, electrophysiologic studies
demonstrate that the thalamus is integral to seizure genera-
tion35; EEG–functional MRI (fMRI) studies have shown
thalamic activation and cortical deactivation during
GSW36,37; and brain connectivity studies indicate thalamo-
cortical circuit abnormalities in patients with GGE.38 How-
ever, the pathophysiologic mechanisms explaining the
relationship between GGE and thalamic volume loss are
still unknown. One possible mechanism might relate to
genetic variation in bromodomain containing 2, reported in
JME patients,39 which has been found to lead to c-amino-
butyric acid (GABA)ergic neuron deficit found in mice40;
this might associate with thalamic volume loss as reported
here.
Although our approach did not allow us to identify indi-
vidual thalamic nuclei, abnormalities of thalamic shape
appeared to be in the vicinity of the pulvinar, anterior
nuclei, lateral posterior, and lateral dorsal nuclei. These
areas connect to cingulate, caudate, putamen, frontal cortex,
supplementary motor area, postcentral cortex, and occipital
cortex,41 all cortical areas that are associated with
GGE.36,42,43
For the first time, we have demonstrated that thalamic
volume loss is present at the onset of GGE in AED-naive
patients. From this evidence, we suggest that thalamic vol-
ume loss is related to disease mechanisms and not solely a
consequence of treatment or longstanding seizures.
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